Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Biomatrix's viscosupplementation product to be distributed by Bayer

May 2, 1997

Clodronate shows comparable efficacy to indomethacin in a rat model of arthritis

May 2, 1997

Potent, selective and orally active COX-2 inhibitors from Parke-Davis

April 30, 1997

Potent and selective iNOS inhibitor disclosed by Merck & Co.

April 29, 1997

Genelabs reports preliminary results from phase III trial of GL-701 for lupus

April 28, 1997

Antiarthritic activity and mechanism of action of mercaptoethylguanidine

April 25, 1997

Signal describes agents that block transcription factor activation

April 24, 1997

Phase III results for TS-110 in osteoarthritis

April 23, 1997

Caspase-1 involved in the regulation of multiple cytokines

April 21, 1997

Royce Laboratories' generic antiinflammatory approved by FDA

April 18, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...